United States DNA Gyrase Subunit B (EC 5.99.1.3) Market was valued at USD 0.15 Billion in 2022 and is projected to reach USD 0.30 Billion by 2030, growing at a CAGR of 10% from 2024 to 2030.
The US DNA Gyrase Subunit B (EC 5.99.1.3) market has been gaining significant attention in recent years, driven by increasing demand for targeted antibiotics and advancements in genetic research. DNA Gyrase, an essential enzyme in bacteria, is a prime target for pharmaceutical companies looking to develop antibiotics that can fight bacterial infections. The gyrase enzyme is responsible for introducing negative supercoils into DNA, which is vital for DNA replication and repair in bacteria. Due to its central role, inhibiting DNA Gyrase can lead to bacterial death, making it a prime target for antibiotic development.
Recent developments in the pharmaceutical industry have spurred an increase in research and development surrounding the DNA Gyrase Subunit B. This subunit plays a critical role in bacterial DNA replication, and as antibiotic resistance becomes an increasing global health concern, the focus on effective inhibitors of DNA Gyrase has intensified. The growing demand for better antimicrobial agents has resulted in higher investments in biotechnology and genetic engineering, fueling the growth of the US DNA Gyrase Subunit B market.
Not only is the US market seeing robust growth, but global demand for DNA Gyrase Subunit B inhibitors is expected to grow significantly. Key factors driving the expansion of this market include the rise in bacterial infections, the increased awareness of the importance of precision medicine, and the ongoing research into antibiotic-resistant strains. The rapid development of genetic tools and the focus on high-precision therapies further contribute to the market's growth, which is expected to see a compounded annual growth rate (CAGR) over the next decade.
Companies are investing heavily in innovations to target DNA Gyrase effectively, developing compounds that could offer new solutions to the growing issue of antibiotic resistance. These developments are expected to continue driving the US DNA Gyrase Subunit B market, as it holds immense potential not just in combating bacterial infections, but also in advancing personalized medicine and genetic therapies.
In terms of geographic outlook, the US is poised to remain a key player in the DNA Gyrase Subunit B market, thanks to its strong biotechnology sector, government funding, and robust healthcare infrastructure. However, competition from global markets, especially Europe and Asia, is also growing as these regions increase their investments in genetic research and pharmaceutical innovations. As we continue to witness an evolution in genetic research, the DNA Gyrase Subunit B market, much like the 100 Gigabit Fiber Optic Transceiver Market, is on track for substantial growth in the coming years.
Get an In-Depth Research Analysis of the US DNA Gyrase Subunit B (EC 5.99.1.3) Market Size And Forecast [2025-2032]
Abgentis Limited
AstraZeneca Plc
Daiichi Sankyo Company Ltd
Merck & Co.
Inc
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US DNA Gyrase Subunit B (EC 5.99.1.3) Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US DNA Gyrase Subunit B (EC 5.99.1.3) Market
Recombinant DNA Gyrase Subunit B
Native DNA Gyrase Subunit B
Purified DNA Gyrase Subunit B
Drug Discovery
Genetic Research
Biotechnology
Diagnostics
Pharmaceutical Companies
Biotechnology Firms
Academic Research Institutions
Contract Research Organizations (CROs)
Liquid Formulations
Lyophilized Formulations
Activity-based Formats
Bacterial Sources
Recombinant Sources
Synthetic Sources
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ DNA Gyrase Subunit B (EC 5.99.1.3) Market Research Analysis
1. Introduction of the US DNA Gyrase Subunit B (EC 5.99.1.3) Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US DNA Gyrase Subunit B (EC 5.99.1.3) Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US DNA Gyrase Subunit B (EC 5.99.1.3) Market, By Type
6. US DNA Gyrase Subunit B (EC 5.99.1.3) Market, By Application
7. US DNA Gyrase Subunit B (EC 5.99.1.3) Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US DNA Gyrase Subunit B (EC 5.99.1.3) Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/